Nov 22 Merck & Co will pay roughly $950
million to settle criminal and civil charges that it promoted
the painkiller drug Vioxx for an unapproved use, the U.S.
Justice Department said on Tuesday.
The fine will conclude a long-running investigation into
Merck's promotion of the drug, which was withdrawn from the
market in September 2004. The Justice Department had alleged
that Merck promoted the drug for treating rheumatoid arthritis
before it had been approved for that condition by the Food and
Merck had previously disclosed to investors the anticipated
$950 million charge ahead of the government announcement.